Your session is about to expire
← Back to Search
Hydrogen Peroxide for Skin Cancer
Study Summary
This trial will test whether 30% hydrogen peroxide can help reduce the size of cancerous lesions, potentially avoiding surgery or radiation.
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a skin reaction to light in the past, or have a medical condition that makes your skin sensitive to hydrogen peroxide.The area being studied has unclear or blurry boundaries.You have a condition called Gorlins syndrome which makes you more likely to develop multiple skin cancers. It is important for you to have regular check-ups and catch any cancer early.If you have a weakened immune system, you will not be able to participate because skin cancers can be very aggressive.
- Group 1: 30% hydrogen peroxide
- Group 2: 3% hydrogen peroxide
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what treatments is Hydrogen Peroxide 30% Topical Solution typically applied?
"Hydrogen Peroxide 30 % Topical Solution is a viable therapy for treating ear infection bacterial, seborrheic keratosis, and communicable diseases."
Is there any risk associated with utilizing Hydrogen Peroxide 30 % Topical Solution?
"Because of the absence of efficacy data, our team at Power has concluded that Hydrogen Peroxide 30 % Topical Solution is moderately safe and consequently awarded it a score of 2."
Are there any precedents for this medical experiment?
"Kortuc, Inc. launched the initial clinical trial for Hydrogen Peroxide 30 % Topical Solution back in 2020, which included a cohort of 184 individuals. This study proved successful and saw the drug move to Phase 2 approval status. At present, 3 different trials are running across 5 cities throughout 3 countries internationally."
What is the enrollment cap for this clinical investigation?
"Affirmative. Clinicaltrials.gov reports that this study, which was initially posted on September 1st 2022, is presently enrolling participants. It requires 51 individuals to be recruited from only one site."
Is there still an opportunity to join this clinical trial?
"The records on clinicaltrials.gov demonstrate that this medical trial is actively searching for participants. It was initially published on September 1st 2022, with the most recent post being made on August 29th 2022."
What previous investigations have been conducted involving Hydrogen Peroxide 30 % Topical Solution?
"Currently, 3 medical trials involving Hydrogen Peroxide 30 % Topical Solution are actively enrolling participants. As the majority of studies for this treatment take place in Lucknow, Uttar Pradesh, there exists 9 clinical sites offering it across the nation."
Share this study with friends
Copy Link
Messenger